Adams Respiratory Therapeutics to Webcast Management Presentation at the Adams Respiratory Therapeutics 32nd Annual Health Care Conference

CHESTER, N.J., April 26 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. will provide a live audio webcast of a presentation by Robert D. Casale, chief operating officer, at the Deutsche Bank 32nd Annual Health Care Conference in Washington, D.C., on Thursday, May 3, 2007, at approximately 9:45 a.m. (ET). Casale is expected to talk about the Company's expanded new over-the-counter (OTC) product portfolio, as well as its planned entry into the prescription cough market with Mucinex(R) with Codeine.

A live audio webcast of the presentation can be accessed by going to the Calendar of Events section of Adams' Investor Relations web site, http://investor.adamsrt.com. A replay of the webcast will be available later that day through 5 p.m. on June 4, 2007.

About Adams Respiratory Therapeutics, Inc.

Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.

Adams Respiratory Therapeutics, Inc.

CONTACT: Janet M. Barth of Adams Respiratory Therapeutics, Inc.,+1-908-879-2428

MORE ON THIS TOPIC